Sanofi (SNY) beats third-quarter estimates for earnings but misses the same for sales. It announces plans to separate its Consumer unit into a new public listed company.
The French drugmaker’s shares dropped more than 15% Friday morning on the announcement that it has abandoned its goal of a 32% operating profit margin for 2025, focusing on long-term profitability.
For children and adolescents with newly diagnosed type 1 diabetes, two 12-day courses of teplizumab show benefit for preservation of beta (β)-cell function.
At ESGCT, Precigen Data Supports Its Lead Candidate as RRP Treatment genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.